Supply High Quality Prl-8-53/Prl-8-53 Powder CAS 51352-87-5
GMP ISO 11 Inquiries
51352-87-5
99%
XAZB
Foil Bag, Drum
2022-12-31
Herb Extracts,Cosmetic raw materails,API
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionProduct description
PRL-8-53 is a nootropic research chemical derived from benzoic acid and phenylmethylamine (Benzylamine) that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.
FunctionsThe benefits of PRL-8-53 aren't fully known, but it is generally considered to be a memory and learning enhancer. In the lone study with rats, taking PRL-8-53 120 - 150 minutes before a cognitive test helped drastically. Memory was tested at 24 hours after dosing and 96 hours with positive results compared to a placebo.
Within these tests, some of the test performance improvements were in the range of 80 - 100+%, which suggests significant potential.
The study separated the analysis of memory and "working memory", which showed less improvement, but still notable.
Product photos
CertificatesBasic Info-
Product Name:
PRL-8-53
Other Name:PRL-8053;PRL-8-53;Methyl 3-(2-(benzyl(Methyl)aMino)ethyl)benzoate hydrochloride;PRL-8-53 HCL;3-(2-Benzyl(methyl)aminoethyl)benzoic acid methyl ester hydrochloride;m-[2-(Benzylmethylamino)ethyl]benzoic acid methyl ester hydrochloride;Benzoic acid, 3-(2-(Methyl(phenylMethyl)aMino)ethyl)-, Methyl ester, hydrochloride;Methyl 3-(2-(benzyl(methyl)
CAS No.:51352-87-5
Molecular Formula:C18H22ClNO2
InChIKeys:HLBBSWSJLPLPRU-UHFFFAOYSA-N
Molecular Weight:319.82578
EC Number:206-141-6
Categories:
Characteristics-
Toxicity:
PRL-8-53 is relatively non-toxic, with an oral LD50 in mice of 860 mg/kg, giving the drug a high therapeutic index. Doses above 8 mg/kg have brief hypotensive effects in canines. High doses depress motor activity in the rat and mouse, with the ED50 for a 50% reduction in motor activity of mice at 160 mg/kg. PRL-8-53 displays spasmolytic effects.
Critical Temperature & Pressure:under inert gas (nitrogen or Argon) at 2-8°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Herb Extracts,Cosmetic raw materails,API
-
Location:
1403,Jinye B Block
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
8
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2015
-
-
Inquiry History11 Inquiries
Country Product Purchase Quantity Date Posted 
Russia
PRL-8-53
10.00 G Aug 14, 2024 
United States
PRL-8-53
1 G Feb 2, 2025
Russia
Sofosbuvir
68.00 G Aug 14, 2024
Russia
Enclomiphene
100.00 G Aug 14, 2024
Russia
7,8-Dihydroxyflavone
75.00 G Aug 14, 2024
Russia
Citicoline sodium
750.00 G Aug 14, 2024
Russia
NNMTi
15.00 G Aug 14, 2024
Russia
Velpatasvir
17.00 G Aug 14, 2024
Russia
Unifiram
30.00 G Aug 14, 2024
Russia
Coluracetam
100.00 G Aug 14, 2024
Russia
DIHEXA
50.00 G Aug 14, 2024 Post an enquiry for this product
